William Blair Cuts Seracare Life Sciences to Mkt Perform

Cites uncertainties about the company's credibility

William Blair cut Seracare Life Sciences (SRLS ) to market perform from outperform, citing the company's recent announcement of an internal review.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.